In Your State Delaware

In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.

Economic Impact In Your State: Delaware

The overall economic impact of the biopharmaceutical industry on the U.S. economy is substantial. The biopharmaceutical industry accounted for more than $1.2 trillion in economic output, representing 3.8 percent of total U.S. output in 2014. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.

$8.4 B

Total output supported by biophamaceutical sector

$302,968

Output per employee in direct biopharmaceutical sector jobs

40,308

Total Jobs

11,205

Direct Jobs

Clinical Trials in Your State: Delaware

Clinical trials are vital to determining the impact of a new potential treatment. They are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments.

133

Total Clinical Trials

10.4

Invested in Clinical Trials

1,544

Clinical Trial Participants

23.6

Total Economic Impact of Clinical Trial Investments